ERGORESEARCH RANKS 307th FASTEST GROWING COMPANY IN NORTH AMERICA ON DELOITTE’S 2012 TECHNOLOGY FAST 500
Publié le 14 novembre 2012 dans Non classé
Ergoresearcch Ltd (TSX-V: ERG) is again confirming its status as Quebec’s leading developer and manufacturer of « intelligent » foot orthotics and specialty orthotics, by securing a 307th spot on Deloitte’s Technology Fast 500TM, a ranking of the 500 fastest growing technology, media, telecommun犀利士
ications, life sciences and clean technology companies in North America. This ranking is based on percentage fiscal year revenue growth from 2007 to 2011 – Ergoresearch grew 248% during that period.
“Each day, our mission is to improve the quality of life of our patients by combining our most recent proprietary technology with our team’s savoir-faire,” affirmed Sylvain Boucher, President and CEO of Ergoresearch. “This recognition not only testifies to the success of our business model which is based on innovation and corporate acquisitions, but also to the commitment and excellence of the professionals at each and every one of our satellite clinics, all across Québec, working under the Clinique du pied Équilibre and Orthoconcept banners,” he specified.
The 2012 Technology Fast 500TM winners are true leaders who leverage their entrepreneurship and technological innovation to achieve strong growth, said Richard Lee, National Leader, Technology, Media & Telecommunications Industry Group, Deloitte. “Their commitment and leadership continue to transform the technology sector.
About Deloitte’s 2012 Technology Fast 500TM
Technology Fast 500, conducted by Deloitte & Touche LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies – both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2007 to 2011.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property of technology that is sold to customer in products that contribute to a majority of the company’s operation revenues. Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, companies must be in business for a minimum of five years, and be headquartered within North America.
Ergoresearch has developed Quebec’s leading network of orthotics clinics, with over 60 corporate and satellite centres under the Clinique du pied Équilibre and Orthoconcept banners. The leading manufacturer of 犀利士
« intelligent » foot orthotics and specialty orthotics, it is a trend-setter in creating durable medical equipment and software for the orthopedics market. Ergoresearch has developed and commercialized Expert-Fit™, the first robotized custom-fit orthotics manufacturing software program, launched the first Living Lab in Canada and more recently, a new generation of world-patented orthotic device called the OdrA, that revolutionizes the treatment of pain associated with knee osteoarthritis. Ergoresearch Ltd is listed on the Toronto Stock Exchange (TSX-V) under the TSX-V Symbol: ERG.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
– 30 –
Sources – Information:
Sylvain Boucher, President and CEO – Ergoresearch Ltd
Tel.: 450-973-6700, ext. 213 / email@example.com
Isabelle Vallée, Director of Communications and Public Relations – Ergoresearch Ltd
Tel.: 450-973-6700, ext. 233 / 514-377-0485 / firstname.lastname@example.org